참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Iodoform | HCID 6374 | — |
| 반응물 | Tert-Butyl nitrite | HCID 10906 | — |
| 반응물 | 7-amino-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one | HCID 59862347 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | 7-Iodo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one | HCID 59403446 | 67.5% |
반응 단계
7-Amino-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one (may be prepared as described in: Preparation of benzazepinylpyrrolidonylsulfonamides as Factor Xa inhibitors; WO2007059952) (500 mg, 2.84 mmol) and triiodomethane (2234 mg, 5.67 mmol) were dissolved in THF (100 ml). Then 1,1-dimethylethyl nitrite (0.675 ml, 5.67 mmol) dissolved in THF (20 ml) was added drop-wise over 20 minutes and the resultant solution stirred for 1 hour. The mixture was heated at 50° C. for 30 minutes. Most of the solvent was removed by evaporation and the crude subjected to biotage chromatography (EtOAc/hexane 3:1) to yield the title compound (550 mg) as a pale yellow solid. MS (ES) C10H10INO requires 287: found 287.8 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08222245B2 |
|---|
| 출처 데이터셋 | uspto-grants-2012_07 |
|---|
| ORD ID | ord-82bf89fe5c9f49afa4d085b51302de0d |
|---|
| 출처 메모 | uspto-grants-2012_07 |
|---|